Real-world Study of Aflibercept 8 mg in nAMD

NCT07640997 · clinicaltrials.gov ↗

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Neovascular Age-Related Macular Degeneration (nAMD)

Interventions

DRUG: Aflibercept 8mg

Sponsor

Peking University People's Hospital

Collaborators

[object Object]